Re-engineering India's Pharma Manufacturing — One Process at a Time
Siprichem Innolab LLP delivers cost-effective API consultancy, pharmaceutical impurity standards, and next-generation flow chemistry solutions to help Indian manufacturers compete globally.
Three Pillars of Innovation
From consultancy to technology licensing, our work is built to deliver real value — helping manufacturers cut costs, improve quality, and modernise operations.
Process Consultancy & Optimisation
We audit MSME pharma factories and deliver measurable cost reduction — improving yields, reducing solvent use, and meeting evolving regulatory requirements.
Pharmaceutical Impurity Standards
High-purity reference standards for drug quality testing — essential for FDA/EMA approvals. We synthesise and supply them domestically.
Flow Chemistry & Technology Licensing
Proprietary continuous flow processes for high-demand APIs, licensed to bulk manufacturers — enabling modern, scalable production.
₹1.2 Lakh Crore Import Gap — India's Chance to Close It
India is the world's 3rd-largest pharmaceutical producer by volume, yet imports 60–70% of key API ingredients from China every year.
India's Major API Import Categories (₹ Crores/year)
Source: PHARMEXCIL / MoC&I 2024–25
